Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Ugeskrift for Laeger
|
January 24, 2015
[Acrometastasis from breast cancer after the use of frozen gloves by adjuvant chemotherapy]
Louise Brygger, Søren Cold
Ugeskrift for Laeger
|
September 20, 2007
[Primary inoperable breast cancer]
Julie Jørgensen, Søren Cold, Claus Kamby
Journal of the National Cancer Institute
|
May 22, 2023
Response to Van Cauwenberge, Borremans, Van Houdt, et al
Søren Cold, Maj-Britt Jensen, Bent Ejlertsen
Acta Oncologica (Stockholm, Sweden)
|
October 31, 2018
Treatment of advanced HR+/HER2- breast cancer with new targeted agents in combination with endocrine therapy: a review of efficacy and tolerability based on available randomized trials on everolimus, ribociclib, palbociclib and abemaciclib
Tea M Bøttcher, Søren Cold, Anders B Jensen
European Journal of Endocrinology
|
August 23, 2008
Elevated free IGF2 levels in localized, early-stage breast cancer in women
Ulrick Espelund, Søren Cold, Jan Frystyk, et al.
Danish Medical Journal
|
December 3, 2020
Neoadjuvant chemotherapy for primary operable breast cancer
Anne Krag Halberg, Charlotte Dahl Gravesen, Søren Cold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
Comparison of gene sets for expression profiling: prediction of metastasis from low-malignant breast cancer
Mads Thomassen, Qihua Tan, Freyja Eiriksdottir, et al.
International Journal of Cancer
|
November 30, 2006
Prediction of metastasis from low-malignant breast cancer by gene expression profiling
Mads Thomassen, Qihua Tan, Freyja Eiriksdottir, et al.
Future Oncology (London, England)
|
November 25, 2011
No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls
Tomasz K Wojdacz, Britta B Thestrup, Søren Cold, et al.
Journal of the National Cancer Institute
|
November 21, 2022
Response to Pederson et al. and Chlebowski et al
Søren Cold, Frederik Cold, Maj-Britt Jensen, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Ugeskrift for Laeger
|
January 24, 2015
[Acrometastasis from breast cancer after the use of frozen gloves by adjuvant chemotherapy]
Louise Brygger, Søren Cold
Ugeskrift for Laeger
|
September 20, 2007
[Primary inoperable breast cancer]
Julie Jørgensen, Søren Cold, Claus Kamby
Journal of the National Cancer Institute
|
May 22, 2023
Response to Van Cauwenberge, Borremans, Van Houdt, et al
Søren Cold, Maj-Britt Jensen, Bent Ejlertsen
Acta Oncologica (Stockholm, Sweden)
|
October 31, 2018
Treatment of advanced HR+/HER2- breast cancer with new targeted agents in combination with endocrine therapy: a review of efficacy and tolerability based on available randomized trials on everolimus, ribociclib, palbociclib and abemaciclib
Tea M Bøttcher, Søren Cold, Anders B Jensen
European Journal of Endocrinology
|
August 23, 2008
Elevated free IGF2 levels in localized, early-stage breast cancer in women
Ulrick Espelund, Søren Cold, Jan Frystyk, et al.
Danish Medical Journal
|
December 3, 2020
Neoadjuvant chemotherapy for primary operable breast cancer
Anne Krag Halberg, Charlotte Dahl Gravesen, Søren Cold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
Comparison of gene sets for expression profiling: prediction of metastasis from low-malignant breast cancer
Mads Thomassen, Qihua Tan, Freyja Eiriksdottir, et al.
International Journal of Cancer
|
November 30, 2006
Prediction of metastasis from low-malignant breast cancer by gene expression profiling
Mads Thomassen, Qihua Tan, Freyja Eiriksdottir, et al.
Future Oncology (London, England)
|
November 25, 2011
No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls
Tomasz K Wojdacz, Britta B Thestrup, Søren Cold, et al.
Journal of the National Cancer Institute
|
November 21, 2022
Response to Pederson et al. and Chlebowski et al
Søren Cold, Frederik Cold, Maj-Britt Jensen, et al.
Page
of 5